Pharma & Biotech Outsourcing challenges

---

Drug development involves a series of complex scientific and strategic decisions –from selecting the right drug delivery approach to identifying the best development and manufacturing partners.

Many companies must navigate these choices with limited internal resources while under pressure to accelerate timelines and reduce risk.  Others struggle with identifying strategic alternatives to incumbents, or uncovering innovation in drug delivery.

evolve provides independent, experienced guidance to help Pharma & Biotech teams make better decisions earlier in development.

Whether you are struggling with Oral Bioavailability challenges, Modified Release or Drug Delivery to the Lung, choosing the right drug delivery technology early can significantly influence development timelines, regulatory risk, and commercial potential.

evolve provides independent scientific and strategic evaluation of drug delivery options to support robust development strategies.

The global CDMO market is heavily fragmented and fiercely competitive, with vendors eager to land a deal often overselling both capabilities and expertise. Identifying the right partner for your Problem Statement that, in addition, meets of all your corporate requirements —development stage, cultural fit, pricing— can be challenging, just like identifying commercially viable drug delivery technologies.

evolve helps companies:

• Choose from a curated portfolio of pre-vetted Tech/Services providers
• Identify and evaluate suitable CDMOs
• Tap into extensive global network, access to stakeholders
• Assess technical capabilities and technology fit
• Structure collaborations
• Avoid common outsourcing pitfalls

Early technical and strategic decisions often determine long-term success.

evolve supports scientists and leaders by providing:

• Independent technical evaluation
• Development strategy input
• Risk identification and mitigation at every step of the way

Examples of support include:

• Advising on formulation and drug delivery strategies
• Supporting development planning, outsourcing decisions
• Identifying, evaluating and contracting outsourcing partners
• Providing independent expert perspective at key development milestones

evolve combines:

• Deep scientific expertise in drug delivery and formulation
• Commercial leadership experience
• A broad network across CDMOs and service providers

This combination allows companies to access independent, experienced guidance when critical decisions need to be made.